Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank93
3Y CAGR+157.6%
5Y CAGR+53.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+157.6%/yr
vs -26.9%/yr prior
5Y CAGR
+53.9%/yr
Recent acceleration
Acceleration
+184.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
8.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$37.36M-19.9%
2024$46.65M+138.3%
2023$19.58M+796.0%
2022$2.19M+501.9%
2021$363000.00-91.6%
2020$4.33M-60.7%
2019$11.02M+43.7%
2018$7.67M+1274.7%
2017$558000.00+1055.2%
2016$48303.00-